Earnings call transcript: Star Buffet Q4 2025 shows revenue decline, debt focus

Star Buffet Inc. (STRZ) reported a 6.8% year-over-year revenue decline in Q4 2025, totaling $326.2 million, but saw a significant increase in adjusted OIBDA, rising $42.6 million to $92 million. Despite the revenue dip, the company projects sequential revenue growth for the latter half of 2025 and year-over-year growth in 2026, driven by a focus on reducing content spending and deleveraging to a target ratio of 2.5x; however, InvestingPro analysis suggests the company may be currently overvalued given its market capitalization of $275.72 million and trailing twelve-month EBITDA of $800.1 million.

Analysis

Star Buffet Inc. (STRZ), following its separation from Lionsgate, reported divergent Q4 2025 results: revenue fell 6.8% year-over-year to $326.2 million due to a weaker content slate in fiscal 2025 and ongoing linear subscriber pressures, while adjusted OIBDA surged by $42.6 million to $92 million, benefiting from reduced programming amortization and marketing expenses, alongside a $177.4 million restructuring charge. Strategically, STRZ is focused on deleveraging, targeting a reduction in its leverage ratio from 3.1x (with $615.5 million total net debt at quarter-end) to 2.5x, and plans to cut annual content expenditure from its current $800 million level towards an ultimate goal of $650 million, aiming for $700 million in 2026. Management projects sequential revenue growth in the latter half of 2025, a return to positive year-over-year revenue growth in 2026, and aims for approximately $200 million in adjusted OIBDA annually, with a long-term vision of 20% margins by calendar 2028 through increased owned intellectual property. Despite these operational improvements, a "GOOD" financial health score (2.59) from InvestingPro, and analyst price targets ranging $15 to $30, InvestingPro analysis also suggests STRZ, with a $275.72 million market capitalization against a reported trailing twelve-month EBITDA of $800.1 million, may be currently overvalued; however, the company trades at 0.3 times book value, and its CEO believes it is undervalued, expecting it to trade significantly higher than its current mid-four times adjusted OIBDA multiple calculated on the projected $200 million annual adjusted OIBDA.

Key Decisions for Investors

• Investors should closely monitor STRZ's execution on its deleveraging plan towards the 2.5x target and its ability to achieve projected content cost reductions, as these are crucial for margin expansion and achieving its 70% adjusted OIBDA to unlevered free cash flow conversion target by calendar 2026.
• Given the conflicting valuation signals – InvestingPro's overvaluation assessment versus management's optimism, low price-to-book ratio, and analyst price targets suggesting upside – a cautious approach is warranted; upcoming sequential revenue growth and the return to positive year-over-year revenue growth in 2026 will be key validation points for the company's strategy.
• Evaluate the progress in developing owned intellectual property, aiming for half the calendar '27 slate, and its tangible impact on both cost structure and revenue diversification, as this is central to achieving the 20% margin target by 2028, while remaining cognizant of intense market competition and the existing 3.1x leverage.